These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27856346)

  • 1. Peptidomimetic therapeutics: scientific approaches and opportunities.
    Qvit N; Rubin SJS; Urban TJ; Mochly-Rosen D; Gross ER
    Drug Discov Today; 2017 Feb; 22(2):454-462. PubMed ID: 27856346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.
    Gentilucci L; De Marco R; Cerisoli L
    Curr Pharm Des; 2010; 16(28):3185-203. PubMed ID: 20687878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal chemistry insights into antiviral peptidomimetics.
    Ding D; Xu S; da Silva-Júnior EF; Liu X; Zhan P
    Drug Discov Today; 2023 Mar; 28(3):103468. PubMed ID: 36528280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided design of amino acid-based therapeutics: a review.
    Farhadi T; Hashemian SM
    Drug Des Devel Ther; 2018; 12():1239-1254. PubMed ID: 29795978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-AApeptides: Design, Structure, and Applications.
    Shi Y; Teng P; Sang P; She F; Wei L; Cai J
    Acc Chem Res; 2016 Mar; 49(3):428-41. PubMed ID: 26900964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The practice of ring constraint in peptidomimetics using bicyclic and polycyclic amino acids.
    Hanessian S; Auzzas L
    Acc Chem Res; 2008 Oct; 41(10):1241-51. PubMed ID: 18646869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
    Mizuno A; Matsui K; Shuto S
    Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications and modifications of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) in peptides and peptidomimetics design and discovery.
    Zhang Y; Fang H; Xu W
    Curr Protein Pept Sci; 2010 Dec; 11(8):752-8. PubMed ID: 21235510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide scanning for studying structure-activity relationships in drug discovery.
    Jamieson AG; Boutard N; Sabatino D; Lubell WD
    Chem Biol Drug Des; 2013 Jan; 81(1):148-65. PubMed ID: 23253136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic peptides and peptidomimetics.
    Kieber-Emmons T; Murali R; Greene MI
    Curr Opin Biotechnol; 1997 Aug; 8(4):435-41. PubMed ID: 9265722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetics: Fmoc solid-phase pseudopeptide synthesis.
    Cudic P; Stawikowski M
    Methods Mol Biol; 2008; 494():223-46. PubMed ID: 18726577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing Peptidomimetics.
    Perez JJ
    Curr Top Med Chem; 2018; 18(7):566-590. PubMed ID: 29788887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide and protein mimetics by retro and retroinverso analogs.
    Rai J
    Chem Biol Drug Des; 2019 May; 93(5):724-736. PubMed ID: 30582286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
    Goyal D; Shuaib S; Mann S; Goyal B
    ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topochemical design of bioactive peptides and peptidomimetics.
    Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
    Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azapeptides -A History of Synthetic Milestones and Key Examples.
    Fan Cheng K; VanPatten S; He M; Al-Abed Y
    Curr Med Chem; 2022; 29(42):6336-6358. PubMed ID: 35538801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidomimetic toolbox for drug discovery.
    Lenci E; Trabocchi A
    Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics.
    Liskamp RM; Rijkers DT; Kruijtzer JA; Kemmink J
    Chembiochem; 2011 Jul; 12(11):1626-53. PubMed ID: 21751324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists.
    Swedberg JE; Schroeder CI; Mitchell JM; Durek T; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Liras S; Price DA; Craik DJ
    Eur J Med Chem; 2015 Oct; 103():175-84. PubMed ID: 26352676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.